Rebecca Lucey

Statistics

Publications

Citations

H-Index

Active since

2024

Affiliations

University College London(Current)

University Hospitals Bristol and Weston NHS Foundation Trust

Royal Devon & Exeter NHS Foundation Trust

University of Cambridge

Worcestershire Acute Hospitals NHS Trust

Rebecca Lucey is an author at University College London specializing in chemotherapy, combination chemotherapy, and triple-negative breast cancer therapy.

ORCID

Publications per year

2024–2025

Publications

The PARTNER trial of neoadjuvant olaparib with chemotherapy in triple-negative breast cancer

Jean Abraham, Karen Pinilla, Alimu Dayimu et al. · Nature · 2024 · 47 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Neoadjuvant PARP inhibitor scheduling in BRCA1 and BRCA2 related breast cancer: PARTNER, a randomized phase II/III trial

Jean Abraham, Lenka Oplustil O’Connor, Louise Grybowicz et al. · Nature Communications · 2025 · 15 citations · Full text

Medicine, Oncology, Pharmacology +17

1–2 of 2